TriStar Technology Group Competitors

DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com.

HD Biosciences Co., Ltd.(HDB) is a biology-focused preclinical contract research organization (CRO). The company offers comprehensive service platforms in target validation, plate-based pharmacology, hit identification, lead discovery, SAR-focused MedChem, therapeutic antibody discovery, in vivo pharmacology, and DMPK/Tox. HDB currently collaborates with eight of the world's ten largest pharmaceutical companies and has established strategic partnership with impact to their portfolios. Our strong scientific expertise and high quality deliverables constantly meet or exceed clients’ expectations, which have helped the company build a great reputation in the industry as well as its widely recognized leadership in preclinical contract research services.

QuickBiology is a fully automated, high-throughput genomic center equipped with all major next generation sequencing. QB provides state-of-the-art genomics technologies, comprehensive services, specialized expertise enabling these services in a cost-effective and timely manner to serve basic science and translational/clinical research. QB’s service included, but not limited to, RNA sequencing, whole exome sequencing, whole genome sequencing, ATAC sequencing and single cell RNA sequencing.